Abstract The coronavirus disease 2019 (COVID-19) pandemic has affected> 610 million
people globally, exerting major social, economic, and health impacts. Despite the large …

COVID-19 and our public health responses to the pandemic may have far-reaching
implications for cardiovascular (CV) risk, affecting the general population and not only …

Abstract In March 2020, the Coronavirus disease 2019 (COVID-19) outbreak was officially
declared a global pandemic, leading to closure of public facilities, enforced social distancing …

Since its outbreak in December 2019 in China, COVID-19 has spread like wild fire to affect
many communities of the world. The high infectivity and case fatality rates of the disease …

Since the very beginning of the coronavirus disease 2019 (COVID-19) pandemic in early
2020, it was evident that patients with cardiovascular disease (CVD) were at an increased …

ABSTRACT Introduction: Coronavirus disease 2019 (COVID-19) cases are increasing
rapidly worldwide. Similar to Middle East respiratory syndrome where cardiovascular …

Background Identification of high-risk groups is needed to inform COVID-19 vaccine
prioritization strategies in Canada. A rapid review was conducted to determine the …

First documented in China in early December 2019, the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread rapidly and continues to test the strength of …

Background: The emergence of novel coronavirus disease 2019 (COVID-19), caused by the
Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2), has presented an …

In December 2019, an unprecedented outbreak of the novel coronavirus disease 2019
(COVID-19), an infectious disease caused by the severe acute respiratory syndrome …